Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Principal Investigator
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey. Lancet Gastroenterol Hepatol. 2022 05; 7(5):390-391.
View in:
PubMed
subject areas
Crohn Disease
Humans
Inflammatory Bowel Diseases
Surveys and Questionnaires
authors with profiles
David Rubin